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Summary 
The proteoglycans synthesized by human osteoarthritic femoral head cartilage and nonarthritic articular cartilage 
age-matched to the osteoarthritic cartilage specimens was studied in explant cultures and in chondrocytes generated by 
explant outgrowth from the cartilages. Twenty-four hours after explanation, both nonarthritic articular cartilage and 
osteoarthritic cartilage synthesized principally one large proteoglycan core protein that migrated on 3-5% acrylamide 
gels with an apparent molecular mass (Mr) of ~520kDa after enzymatic digestion with chondroitinase ABC and 
keratanase. The proteoglycan was found in both the explant itself and in the medium compartment of the culture as well. 
This proteoglycan contained chondroitin-6-sulfate, k ratan sulfate and the hyaluronan binding region as evidenced by 
immunoblotting with murine anti-proteoglycan monoclonal antibodies indicating that the proteoglycan was aggrecan. 
To a much lesser extent wo additional proteoglycan core proteins were also found in the explant but were not seen in 
the culture medium compartment. These proteoglycans possessed apparent Mr's of ~ 480 kDa and ~ 390 kDa on 3-5% 
acrylamide gels after chondroitinase ABC and keratanase digestion. The medium compartment contained principally the 
520 kDa proteoglycan core protein. In osteoarthritic cartilage xplants, the pattern of newly synthesized proteoglycans 
recovered from the tissue as assessed on 3-16% polyacrylamide gradient gels remained relatively the same from day 1 
after explantation up to 36 days of culture. By contrast, the proteoglycans recovered from the culture medium contained 
chondroitin sulfate and keratan sulfate after 1, 7 and 21 days in culture but by 36 days appeared to contain only chondroitin 
sulfate. Chondrocytes generated from osteoarthritic artilage and age-matched nonarthritic articular cartilage 
synthesized ifferent patterns of large (greater than 200 kDa) proteoglycan. Whereas chondrocytes derived from 
osteoarthritic cartilage continued to synthesize principally the ~ 520 kDa proteoglycan core protein, the chondrocytes 
derived from nonarthritic artilage synthesized in addition to this proteoglycan, abundant amounts of the other two 
proteoglycan core proteins as well. 
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Introduction 
HUMAN OSTEOARTHRITIS of the per iphera l  hip 
and knee jo ints  is a severely debi l i tat ing disease 
found a lmost  universa l ly  among the elderly which 
resul ts  in s ignif icant and i rrevers ible dest ruct ion  of 
synovia l  jo int  a r t i cu la r  cart i lage [1, 2]. Ar t i cu la r  
cart i lage proteoglycan synthesis  in response to an 
init ia l  cart i lage insult  may be required to faci l i tate 
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cart i lage repa i r  and per turbat ions  in proteoglycan 
compensatory  synthesis  could be responsib le  for 
osteoar thr i t i s  disease progress ion [2]. In  addit ion, 
the types of proteoglycans ynthesized by osteo- 
ar thr i t i c  cart i lage, as dist inct  from the specific 
amounts  of proteoglycan,  may play an  impor tant  
ro~le in determin ing the funct ional  character is t ics  of
the cart i lage extrace l lu lar  matr ix.  
One hypothes is  has stated that  chondrocyte  
compensatory  b iosynthet ic  processes were com- 
promised by a substant ia l  increase in the tran- 
scr ipt ion, b iosynthes is  and act ivat ion of matr ix  
meta l loprote inases  (pr incipal ly stromelysin-1 and 
col lagenase~ which degraded several  matr ix  pro- 
teins requi red for normal  cart i lage funct ion,  
including proteoglycans,  collagen, l ink prote in  and 
f ibronect in [2, 3-5]. This would be coupled to an  
imbalance between matr ix  meta l loprote inase  yn- 
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thesis and transcription and biosynthesis of the 
tissue inhibitor of metalloproteinase (TIMP-1) 
whose expression would not upregulated to the level 
seen with metalloproteinases [4]. 
Recent evidence, however, has established 
that significant modulation of chondrocyte bio- 
synthetic pathways also occurs in human osteo- 
arthritic cartilage. Thus, type X collagen synthesis, 
normally confined to hypertrophic hondrocytes of 
the zone of calcifying cartilage and growth plate 
cartilage was also detected in osteoarthrit ic 
cartilage [6, 7] and was indeed the major collage- 
nous isotype synthesized by freshly isolated 
chondrocytes from osteoarthrit ic cartilage in vitro 
[8]. Substantial increases in the deposition of ~' 
leucine-rich small proteoglycans, namely, decorin 
[9] and in the cartilage form of fibronectin [10] have 
also been reported in osteoarthrit ic cartilage. 
In the present study, we sought to establish 
whether nonarthrit ic articular cartilage specimens 
age-matched to cartilage specimens obtained from 
osteoarthritic femoral heads acquired at the time of 
joint replacement synthesized proteoglycans that 
were substantially different from one another. In 
addition, modulation of the proteoglycan phenotype 
of human cartilage and chondrocytes generated by 
explant-outgrowth as a function of time-in-culture 
was studied. 
Materials and methods  
Chondroitinase ABC, chondroitinase-AC-II and 
endo-fl-galactosidase (keratanase) were obtained 
from ICN Immunologicals (Irvine, CA, U.S.A.). 
Agarose and acrylamide for gel electrophoresis 
were obtained from FMC Bioproducts (Rockland, 
ME, U.S.A.) and ICN Biomedicals (Irvine, CA, 
U.S.A.), respectively. Sodium borohydride was 
purchased from Fisher Scientific (Fairlawn, NJ, 
U.S.A.). All other chemicals were ACS grade or their 
equivalent. Anti-proteoglycan monoclonal antibody 
1C6 (anti-hyaluronic acid binding region; HABR) 
was purchased from the Developmental Studies 
Hybridoma Bank (Baltimore, MD, U.S.A.). Mono- 
clonal antibodies 3B3 (anti-chondroitin-6-sulfate), 
2B6 (anti-chondroitin-4-sulfate) and 5D4 (anti-ker- 
atan sulfate) were generous gifts from Dr Bruce 
Caterson (University of North Carolina, Chapel 
Hill, NC, U.S.A.). Na2 35SO4 (carrier free, specific 
activity, 43 Ci/mg at 100% isotope enrichment) was 
from ICN. [35S]-methionine (specific activity, 
1333 Ci/mmol) was from Amersham (Arlington 
Heights, IL, U.S.A.). Eight-day-old chick embryo 
limb bud aggrecan (fraction AID1) was kindly 
provided by Dr David Carrino (Case Western 
Reserve University). 
HEALTH STATUS OF CARTILAGE DONORS 
All osteoarthrit ic cartilage specimens were 
obtained from osteoarthrit ic femoral heads 
of patients undergoing joint replacement for 
disabling osteoarthrit is (Table I). Non-arthritic 
cartilage specimens were obtained from patients 
undergoing joint replacement as a consequence o f  
hip fracture (Table I). A representative autoradio- 
graph (see below) is shown for reporting results of 
proteoglycan synthesis tudies. 
EXPLANT CULTURE 
Cartilage was diced into small pieces (1-2 mm 2) 
and treated briefly with testicular hyaluronidase 
(0.05% w/v) for 3 min at room temperature toremove 
adherent erythrocytes and synovial cells from the 
cartilage surface [11]. For explant-outgrowth, the 
cartilage was divided into groups of 10-15 minced 
pieces, distributed into 60mm 2 culture dishes 
(Falcon; Oxnard, CA, U.S.A.) and maintained in 
Dulbecco's modification of Eagle's medium 
(DMEM) which contained fetal bovine serum 
(10% v/v), penicillin-streptomycin (0.1% v/v) [11], 
mycostatin (0.1% v/v) and fungizone (1% v/v). The 
cultures were maintained in a humidified atmos- 
phere of 10% CO2/90% air at 37°C. The minced tissue 
was not disturbed for 7 days and then the culture 
medium was replaced with fresh medium every 2-3 
days thereafter until chondrocyte confluency was 
attained (usually by 30-40 days) [11, 12]. 
RADIOISOTOPE INCORPORATION 
Cartilage specimens were radiolabeled with ~5SO4 
(100 pCi/ml) in sulfate-free DMEM containing fetal 
bovine serum, antibiotic and antimycotics for 24 h 
on the day of explantation, while other cartilage 
specimens were treated in this manner on days 0, 6, 
20 and 35 of explantation to determine the quality 
of the newly synthesized proteoglycans. All 
cartilage specimens were radiolabeled in parallel 
Table I 
Age and diagnosis of patients' cartilage 
specimens 
Age 
Patient (years) Diagnosis 
1 79 Hip fracture (NA) 
2 80 Osteoarthritis 
3 84 Hip fracture (NA) 
4 79 Osteoarthritis 
5 60 Hip fracture (NA) 
6 65 Osteoarthritis 
NA, nonarthritic. 
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with [3~S]-methionine (100 #Ci/ml) in methionine- 
free Eagle's medium supplemented with fetal bovine 
serum, antibiotics and antimycotics for the same 
time period. Chondrocytes derived by explant-out- 
growth were briefly treated with pancreatic trypsin 
at 37°C [11, 12], the cells pelleted by low-speed 
centrifugation and replated at high initial cell 
density (2-3×105/ml) in 1.2cm 2 surface area 
multiwell dishes (Falcon). After 2 days, the 
chondrocytes were radiolabeled with 35SO4 or with 
[3~S]-methionine for 24 h. 
PROTEOGLYCAN EXTRACTION 
The cartilage explant or chondrocyte cell layer 
(cell-associated fraction; CAF) was extracted with 
4 M guanidine hydrochloride (GuHC1)/0.2 M sodium 
acetate, pH 5.8 containing proteinase inhibitors [13] 
for 24 h at 4°C. The culture medium compartment 
was mixed 1:1 with 8 M GuHC1 containing 
proteinase inhibitors and kept at 4°C overnight. The 
explant or CAF 4 M GuHC1 extract and 4 M GuHC1 
extract of the culture medium compartment were 
separately exhaustively dialyzed using 6-8kDa 
cutoff membranes against double-distilled de- 
ionized water at 4°C. The retained material was 
freeze-dried and stored at -80°C. 
DENSITY GRADIENT ULTRACENTRIFUGATION 
The newly synthesized proteoglycans were 
resolved from the bulk of the cellular proteins by 
density gradient ultracentrifugation under isso- 
ciative conditions [13]. The gradient fractions [D4 
(top) to D1 (bottom)] were exhaustively dialyzed and 
freeze-dried. Final densities of these fractions were 
as previously reported [13]. 
COMPOSITE AGAROSE-POLYACRYLAMIDE GEL 
ELECTROPHORESIS (CA-PAGE) 
D1, D2, D3 and D4 fractions radiolabeled with 
35SO4 were electr0phoresed as previously described 
[14] and autoradiographs produced using Kodak 
X-Omat m film and D-19 developer. 
POLYACRYLAMIDE OR ACRYLAMIDE GEL 
ELECTROPHORESIS 
CsC1 density gradient fractions radiolabeled with 
either 35SO4 or [3~S]-methionine were elec- 
trophoresed on 3-16% polyacrylamide slab gels 
containing 0.1% sodium dodecyl sulphate [14]. CsC1 
density gradient fractions were digested with either 
chondroitinase ABC, chondroitinase ABC plus 
keratanase or chondroitinase AC-II as previously 
described [15, 16] prior to electrophoresis. Auto- 
radiographs were produced. In several cases, D1 
fractions radiolabeled with 35SO4 were digested with 
chondroitinase ABC and keratanase and elec- 
trophoresed on 3-5% acrylamide as previously 
described [13] and autoradiographs produced. 
WESTERN BLOT ANALYSIS 
D1 fractions radiolabeled with [3~S]-methionine 
wore digested with chondroitinase ABC and 
keratanase prior to electrophoresis on 3-16% 
gels. The proteins were transferred to Immobilon-P 
membranes (Milliporo, Bedford, MA, U.S.A.) by 
electroelution. The immobiton membrane was 
blocked with gelatin and then incubated with one of 
several anti-proteoglycan monoclonal antibodies 
(mAb). In the case of monoclonal antibody 1C6, the 
D1 fractions were additionally reduced and 
alkylated to reveal the hyaluronic acid binding 
region epitope [17, 18]. Immunoreactivity of proteo- 
glycan core proteins with mAbs 1C6, 3B3, 5D4 and 
2B6 were developed with rabbit or goat anti-mouse 
IgG or IgM (#-chain specific) which was conjugated 
to alkaline phosphatase [16]. 
Resu l ts  
PROTEOGLYCANS SYNTHESIZED BY NONARTHRITIC 
CARTILAGE AND OSTEOARTHRITIC CARTILAGE 
EXPLANTS 
D1 fractions were prepared from 4 M GuHC1 
extracts of osteoarthrit ic artilage explants and 
from 4 M GuHC1 extracts of the culture medium 
compartment. Qualitative alterations in the large 
(greater than 200kDa) proteoglycans recovered 
from the D1 fractions were studied as a function 
of time in culture. D1 fractions radiolabeled 
with either ~SO4 or [3~S]-methionine on the day of 
sample acquisition (day 0) or after 6, 20 and 35 days 
in culture were electrophoresed on 3-16% SDS- 
PAGE. The results of this analysis was compared to 
results obtained from chondrocytes derived from the 
osteoarthrit ic cartilage explants. This analysis 
showed that substantial modulation of newly 
synthesized proteoglycans occurred as a function of 
time-in-culture (Fig. 1). In the cartilage explant, 
after 24 h [Fig. l(a), day 0], one major proteoglycan 
core protein (L,) was detected and only after 
combined chondroitinase ABC and keratanase 
digestion. Significantly lesser amounts of two other 
proteoglycan core proteins (LH and IIII) were  seen 
[Fig. l(a), lane 3]. The requirement for both 
chondroitinase ABC and keratanase digestion to 
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visualize these proteoglycans persisted for the 
entire 36 days of the study. 
In the. culture medium compartment of the 
explants [Fig. l(b)], up until  day 21, chondroitinase 
ABC and keratanase digestion was required to 
visualize large proteoglycans and principally the L~ 
proteoglycan core protein was detected [Fig. l(b), 
lanes 3, 6, 9]. By contrast, the L~ proteoglycan core 
prot.ein seen after 36 days was produced after 
chondroitinase ABC digestion alone [Fig. l(b), lane 
11]. The migration of the L~ proteoglycan core 
protein did not change after the combined enzyme 
digestion [Fig. l(b), lane 12]. 
In addition to the synthesis of large proteoglycan 
core proteins, osteoarthritic artilage also syn- 
thesized proteoglycans that migrated on 3-16% 
polyacrylamide g ls in the manner characteristic of
small proteoglycans. These small proteoglycans 
(PG-S1, PG-S2) were not readily apparent until 
late (day 36) in the time-in-culture xperiments 
[Figs l(a) & l(b), lane 10]. A broad band of 
radioactivity migrating between the 97.4 kDa and 
30kDa markers was visualized in D1 fractions 
without enzyme digestion ]Fig. l(a), lane 10]. This 
band was completely abolished after chondroitinase 
ABC digestion [Figs l(a) and l(b), lane 11]. This 
band was also detected in chondrocytes generated 
from the explant-outgrowth ]Figure 1(c), lanes i and 
4]. Chondrocytes generated from these osteo- 
arthritic cartilage explants showed persistent 
synthesis of primarily the L~ proteoglycan core 
protein in both the cell-associated fraction (CAF) 
and in the culture medium compartment [Fig. 1(c)]. 
D1 fractions radiolabeled with [~sS]-methionine 
confirmed the results of these analyses on 
35SO4-1abeled D1 fractions (see below). The L, 
proteoglycan core protein was immunoreactive with 
mAb 3B3 after chondroitinase ABC/keratanase 
digestion indicative of the presence of chondroitin- 
6-sulfate. Chondroitinase ABC digested D1 also 
was immunoreactive with mAb 5D4, indicative of the 
presence of keratan sulfate. Chondroitinase ABC/ 
keratanase digested D1 also was immunoreactive 
with mAb 1C6 after reduction and alkylation, 
indicative of the presence of the hyaluronan binding 
domain. Only weak reactivity of D1 was obtained 
with mAb 2B6 after chondroitinase ABC/ker- 
atanase digestion. The immunoreactivity of the D1 
fraction proteoglycan core proteins with mAb 3B3 
after chondroitinase ABC/keratanase digestion was 
identical to the immunoreactivity of mAb 3B3 
obtained with authentic hick limb bud aggrecan. 
The presence of keratan sulfate, the hyaluronan 
binding domain and chondroitin-6-sulfate s rongly 
indicated that the L~ core protein was aggrecan. 
In order to estimate the apparent size (Mr) of the 
1 • 2 
a, ~ dynein 
480, 440 
Mr x 10 -3 
200 m 
97.4 m 
.2  LI 
- -  LII I 
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FIG. 2. Three per cent to 5% acrylamide gel electro- 
phoresis of a human osteoarthritic femoral head cartilage 
D1 fraction. On the day of explanation, a sample of human 
osteoarthritic femoral head cartilage was radiolabeled 
with asSO4 for 24 h and a D1 fraction produced from the 
culture medium compartment. The D1 fraction was 
digested with chondroitinase/ABC and keratanase and 
electrophoresed on a 3-5% acrylamide Slab gel with 
dithiothreitol and SDS in the running buffer. An 
autoradiograph was produced from the dried gel. Lane 1, 
14C-methylated protein markers and the migration 
position of the ~,fi chains of dynein possessing MT's of 
480 kDa and 440kDa, respectively [see 13]. Lane 2, 
35SO4-1abeled D1fraction. 
principal L~ proteoglycan core protein synthesized 
by human cartilage in short-term culture, a D1 
fraction radiolabeled with 35SO4 was digested with 
chondroitinase ABC and keratanase and electro- 
phoresed through 3-5% acrylamide with 0.1% SDS 
in the running buffer as previously described [13]. 
The migration of ~ and // chains of dynein were 
employed to mark the migration position of the L1 
core protein from the origin of the separation gel 
and the 200 kDa myosin~marker protein [13]. These 
results (Fig. 2) revealed that under these electro- 
phoresis conditions, the L~ proteoglycan core 
protein migrated slower than the dynein marker 
(Fig. 2, lane 2), and was the principal proteoglycan 
core protein whose apparent Mr was ~520 kDa. 
Other proteoglycan core proteins (Ln and Lm) 
were also visualized but in lesser amounts. Their 
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apparent Mrs were ~390kDa and ~480kDa, 
respectively. 
For comparison purposes proteoglycan synthesis 
was studied on nonarthrit ic femoral head cartilage 
age-matched to the osteoarthritic femoral head 
cartilage samples (Table I). The percentage ~'~SOcla- 
beled proteoglycan i the D1 fraction from two of 
these nonarthrit ic artilage specimens was 72.3% 
and 71.8% which was similar to those average values 
obtained for osteoarthritic femoral head cartilage 
(Fig. 1). 
Three percent to 16% SDS-PAGE showed that 
nonarthrit ic cartilage explants predominantly 
synthesized the L~ proteoglycan core protein 
after 24h in culture [Figs 3(a) and 3(b)]. A 
proteoglycan core protein migrating with the 
200kDa marker was detected in the medium 
compartment [Figs 3(a), lane 2, 3(b), lane 2] which 
was not seen in the 24 h osteoarthritic cartilage 
explants [Fig. l(a), lane 3]. 
COMPARISON OF PROTEOGLYCANS SYNTHESIZED BY 
CHONDROCYTES FROM OSTEOARTHRITIC CARTILAGE 
WITH CHONDROCYTES FROM AGE-MATCHED 
NONARTHRITIC CARTILAGE 
The proteoglycan profile produced by human 
chondrocytes generated by explant-outgrowth of 
osteoarthritic cartilage and nonarthrit ic artilage 
was analyzed on 35SO4-1abeled CsC1 density gradient 
fractions by autoradiography after CA-PAGE 
(Fig. 4). The proteoglycan profile produced by 
chondrocytes from nonarthrit ic cartilage and 
chondrocytes from osteoarthritic artilage was 
virtually identical. Several proteoglycan sub- 
populations were visualized. The D1 fraction 
contained two proteoglycan populations (PGL and 
PGs). We had previously shown that PGL formed 
proteoglycan aggregates with hyaluronan whereas 
PGs did not [17]. The fast migrating bands in the 
middle and low density D2/D3/D4 fractions (Fig. 4, 
(a) 
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FIG. 3. Proteoglycan synthesis by nonarthritic cartilage. Nonarthritic artilage was radiolabeled with either (a) 3~SO4 or 
(b) pS]-methionine (35S-Met) on the day of sample acquisition for 24 h. D1 fractions were either digested or not digested 
with chondroitinase ABC/keratanase (ABC/KSase) prior to electrophoresis on 3-16% gradient slab gels. The arrow shows 
the migration position of the L1 proteoglycan core protein. The arrowhead denotes a proteoglycan core protein which is 
present in the medium compartment but not in the explant and is migrating slower than the 200 kDa marker protein. 
In (b), the arrow and the arrowhead mark the L, proteoglycan core protein and this additional proteoglycan core protein, 
respectively. The migration of the $1 and $2 core proteins is also indicated. Markers are 14C-methylated proteins as noted 
in Fig. 1. 
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FIG. 4. Composite agarose-polyacrylamide gel electro- 
phoresis of chondrocyte proteoglycans. Chondrocytes 
from nonarthritic or osteoarthritic cartilage were 
radiolabeled with 3~SO4 for 24 h. The newly synthesized 
proteoglycans in the medium compartment were sub- 
jected to CsC1 density gradient centrifugation under 
dissociative conditions. Gradient fractions D4 (top), 
D3, D2 (middle) and D1 (bottom) [see 17] were 
electrophoresed and autoradiographs produced. PGL, 
aggregating proteoglycan [see 17]; PGs, nonaggregating 
proteoglycan [see 17]. NA, nonarthritic; OA, osteo- 
arthritic. 
lanes 1-3, 5-7) and the sl0w migrating band in the 
D4 fraction (Fig. 4, lanes 1 and 5) have not been as 
yet characterized. 
The proteoglycans and other proteins transported 
into the medium compar tment  were further 
analyzed by 3-16% SDS-PAGE of [35S]-methionine- 
labeled CsC1 density gradient fractions (Fig. 5). The 
profiles of the chondrocytes from aged-matched 
nonarthrit ic cartilage (Fig. 5, lanes 1-4) and 
chondrocytes from osteoarthrit ic artilage (Fig. 5, 
lanes 5-8) were virtually identical except for the 
almost complete absence of the LH and LH~ 
proteoglycan core proteins in the D1 fraction of 
the chondrocytes derived from osteoarthrit ic 
cartilage (Fig. 5, lane 8) and marked reduction in the 
intensity of the radioactive signal in the L~ 
proteoglycan core protein relative to the $1, $2 core 
proteins (Fig. 5, lane 8). The L~ proteoglycan core 
protein was also seen in the D2 fraction (Fig. 5, lanes 
3 and 7). The percentage of 3~SO4-1abeled protein in 
the D1 + D2 fraction of the medium compartment in
three nonarthrit ic aged-matched cartilage samples 
(Table I, patients 1, 3 and 5) was 47.4%, 47.1% and 
46.6% compared to 38.8%, 60.7% and 61.8% for 
osteoarthrit ic femoral head cartilage samples 
(Table I, patients 2, 4, and 6). The $1 and $2 core 
proteins were seen primarily in the D1 and D2 
fractions. 
The proteoglycans in the D1 fraction were 
analyzed for susceptibil ity to chondroitinase 
ABC, chondroitinase AC-II digestion or combined 
chondroitinase ABC/keratanase digestion (Fig. 6). 
Under these conditions, most of the newly 
synthesized proteoglycans produced by chondro- 
cytes from non-arthritic and from osteoarthrit ic 
cartilage were transported into the medium 
[Fig. 6(b)]. In the CAF [Fig. 6(a)], only the L~ 
proteoglycan core protein was detected. The LI 
proteoglycan core protein migrated into the gel 
after chondroitinase ABC digestion [Fig. 6(a), lanes 
2 and 6] or after chondroitinase AC-II digestion 
[Fig. 6(a), lanes 4 and 8]. The migration position of 
the L~ proteoglycan core protein was not altered 
after additional keratanase digestion [Fig. 6(a), 
lanes 3 and 7]. By contrast, the medium compart- 
ment contained several proteoglycan subpopu- 
lations [Fig. 6(b)]. In the culture medium 
compartment of chondrocytes from nonarthrit ic 
cartilage, nonenzyme-digested D1 showed the 
presence of a proteoglycan that failed to enter the 
gel, together with two smaller proteoglycans 
[Fig. 6(b), lane 1]. After chondroitinase ABC 
digestion, proteoglycan core proteins, Lx and IH 
could be visualized [Fig. 6(b), lane 2] together with 
radioactive bands $1, $2. Chondroitinase AC-II 
digestion [Fig. 6(b), lane 4] produced similar 
results with a modest increase in migration of 
these bands. When keratanase was added to 
chondroitinase ABC digested D1, an additional core 
protein, LIH could be seen [Fig. 6(b), lane 3]. In 
contrast to the above, in chondrocytes from 
.osteoarthritic artilage the L, proteoglycan core 
protein predominated in D1 fractions digested with 
either chondroitinase ABC or chondroitinase AC-II, 
respectively [Fig. 6(b), lanes 6 and 8, respectively]. 
Addition of keratanase to chondroitinase ABC- 
digested D1 produced only a faint band correspond- 
ing to the Lm proteoglycan core protein; the L,I 
proteoglycan core protein was never detected in any 
abundance [Figure 6(b), lane 7]. Radioactive bands 
corresponding to S,, $2 were also visualized after 
chondroitinase ABC, combined chondroitinase 
ABC/keratanase or chondroitinase AC-II digestion 
[Figure 6(b), lanes 6-8, respectively]. 
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Discussion 
The principle objective of this study was to 
systematically analyze the influence of explant and 
cell culture of human chondrocytes on the stability 
of the proteoglycan phenotype. Aberrant compensa- 
tory extracellular matrix biosynthesis has been 
suggested to account, in part, for the failure of 
articular cartilage to undergo repair as a conse- 
quence of osteoarthritic pathology [2]. Owing to the 
high prevalence of osteoarthritis among the elderly 
population, determinations of the fidelity of the 
proteoglycan repertoire necessitated that control 
cartilage for this study (i.e. nonarthrit ic) be 
age-matched to the osteoarthritic cartilage 
specimens. 
The most abundant newly synthesized large 
proteoglycan core protein of human nonarthrit ic 
cartilage and osteoarthritic artilage produced 
after I day in culture had i entical apparent Mr,  of 
~520kDa after chondroitinase ABC/keratanase 
digestion as estimated by its migration on 3-5% 
acrylamide. Immunoreactivity with a murine mAb 
reactive with keratan sulfate indicated that this 
core protein was aggrecan and not versican. 
Versican and aggrecan are closely related to each 
other [19]. Both core proteins possess a domain 
at the amino-terminal end which binds 
hyaluronan and a lectin domain at the carboxy- 
terminus whose naturally occurring ligand is 
unknown. Both proteoglycans contain chondroitin- 
sulfate. However, versican is devoid of keratan 
sulfate, whereas aggrecan possesses several 
keratan sulfate domains. Immunoblots showed 
that proteoglycan core protein L, contained both 
the hyaluronan binding region and chond- 
roitin-6 sulfate. Chondroitinase ABC/keratanase 
digestion of D1 fractions, however, raised the 
possibility that mAb 1C6 reactivity with the 
proteoglycan core protein L~ was to the G2 globular 
domain as well as to the hyaluronan binding 
region [20]. 
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FIG. 5. Three per cent to 16% gradient gel electrophoresis of proteoglycans synthesized by human chondrocytes. 
Chondrocytes were radiolabeled with [~sS]-methionine for 24 h. The culture medium compartment was subjected to CsC1 
density gradient centrifugation u der dissociative conditions. Gradient fractions were digested with chondroitinase 
ABC/keratanase, lectrophoresed on 3-16% gradient slab gels and autoradiographs produced. LL, Ln, Lm marks the 
position of three proteoglycan core proteins. $1, $2 marks the position of the small proteoglycan core proteins. Rainbow t~" 
marker proteins are myosin, 200 kDa; phosphorylase b, 92.5 kDa; .bovine serum albumin, 66 kDa; ovalbumin, 46 kDa; 
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digestion are indicated in (b) by *. These bands appear to have a greater adiolabeling intensity in lanes 5-8 when 
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The chondroitinase ABC/keratanase digestion of 
nonarthr i t ic  artilage and osteoarthrit ic cartilage 
D1 fractions which was required to visualize 
migration of the newly synthesized proteoglyc~ns 
into 3-!6% gradient slab gels strongly indicated 
that proteoglycan core protein L~ was aggrecan 
[Figs l(a) & l(b)]. In contrast, the results of 
protracted explant culture (36 days) suggested 
a modulation of the proteoglycan phenotype. 
This was especially true of the large proteo- 
glycans transported into the medium compartment 
[Fig. l(b), lane 12]. Thus, the susceptibil ity of the 
large proteoglycans to chondroit inase ABC diges- 
tion in day 36 explant medium compartment and by 
chondrocytes derived from osteoarthrit ic cartilage 
was virtually identical [compare Fig. l(b), lanes 11 
and 12 with Fig. 1(c), lanes 5 and 6]. Either these 
large proteoglycans have a markedly reduced 
keratan sulfate content which was consistent with 
the fact that only chondroit inase ABC digestion was 
required to visualize the L~ core protein, or the 
proteoglycan has a different sulfation pattern which 
could make it resistant o keratanase (A.R. Po01e, 
personal communication). Alternatively, the 
medium compartment could be the repository of a 
versican-like proteoglycan while the explant itself 
~etains aggrecan. A recent study indicated that 
osteoarthrit ic arti lage contained a large chon- 
droitin sulfate proteoglycan which belonged to the 
versican family [21]. The versican core protein was 
estimated to be 550 kDa on polyacrylamide slab gels, 
which was similar in apparent size to the L, 
proteoglycan core  protein found in the culture 
medium of human osteoarthrit ic carti lage xplants 
after 36 days in culture. 
The mechanism resulting in the synthesis of 
different forms of large proteoglycan core proteins 
by human chondrocytes from aged nonarthr i t ic  
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articular cartilage in vitro remains to be eluci- 
dated. The gel patterns shown in Fig. 6(b) do not 
necessarily imply the existence of distinct and 
separate aggrecan core proteins. Certainly post- 
synthesis proteolytic leavage of a single proteogly- 
can core protein could give rise to proteoglycan 
core proteins with characteristics similar to the 
migration pattern of D1 fractions from these 
chondrocytes as seen on 3-16% polyacrylamide 
gels after chondroitinase ABC/keratanase diges- 
tion. Alternatively, differences in amounts of N- or 
O-linked oligosaccharides or in glycosaminoglycan 
substitution among the three core proteins could 
explain the differences in migration. Previous 
studies have also stressed that alterations in 
proteoglycans biosynthesis by chondrocytes de- 
rived from osteoarthritic artilage in vitro could 
imply dysfunction of proteoglycan biosynthesis 
in vivo. [2, 22-25]. 
CA-PAGE showed marked similarities between 
the proteoglycan pattern of chondrocytes from non- 
arthritic cartilage and chondrocytes from osteo- 
arthritic cartilage (Fig. 4). In the D1 fraction, two 
proteoglycan subpopulations were identified (i.e. 
PGL and PGs). The pattern demonstrated by these 
chondrocytes for newly synthesized proteoglycans 
was grossly similar to previously reported results of 
endogenous nonarthrit ic (aged 29 and 82 years) 
cartilage proteoglycans analyzed by CA-PAGE [26]. 
In that study, PGL reacted with antibody specific for 
the HABR and PGs with anti-decorin (small PG II) 
antibody [26]. 
We also found substantial synthesis of 35SO4- 
labeled small proteoglycans [Figure l(a), lane 
10] which resembled the migration profile of the 
leucine-rich proteoglycans, decorin and biglycan 
reported by others [27, 28]. Digestion of D1 fractions 
radiolabeled with [3~S]-methionine (Fig. 3) produced 
two core proteins that migrated somewhat slower 
than the 46 kDa marker protein. These bands were 
likely to be the glycosylated forms of biglycan and 
decorin, respectively. We had previously shown that 
these bands reacted with mAB 2B6 but not mAb 3B3 
after chondroitinase ABC digestion, and did not 
react with mAb 2B6 after chondroitinase AC-II 
digestion [16], suggesting that these proteoglycans 
contained significant amounts of iduronate se- 
quences, characteristic of dermatan sulfate proteo- 
glycans. We have also shown by gel filtration 
chromatography that human osteoarthrit ic hon- 
drocyte strains synthesized a greater amount of 
small proteoglycans than their nonarthrit ic carti- 
lage counterparts and that this small proteoglycan 
was not derived from the large proteoglycans also 
synthesized by these cells [25]. A previous analysis 
of human chondrocytes from osteoarthritic arti- 
lage suggested that synthesis of a large proteoglycan 
containing predominantly dermatan sulfate and 
devoid of keratan sulfate indicated significant 
modulation from the proteoglycan phenotype of the 
parent tissue [22]. However, more recent analyses 
strongly support the view that dermatan sulfate 
proteoglycan synthesis is a normal product of 
articular cartilage [9, 27] and of chondrocytes in 
culture [28]. In the present studies, the proteoglycan 
core protein L~ was strongly reactive with mAb 3B3 
and only marginally reactive with mAb 2B6 after 
chondroitinase ABC/keratanase digestion indicat- 
ing that L~ probably did not contain any significant 
amounts of chondroitin-4-sulfate. : 
None of the analyses performed indicated the 
synthesis of a 59kDa core protein known as 
fibromodulin [29] in the D1 fraction which also 
contained other small proteoglycans. The 3~SO4 seen 
in the CAF or culture medium compartment 
migrating as a broad smear in nonenzyme digested 
D1 fractions was completely abolished by digestion 
with chondroitinase ABC indicating that this smear 
was in all likelihood proteoglycan fragments 
containing chondroitin sulfate. Keratanase diges- 
tion after initial digestion with chondroitinase ABC 
did not alter the migration profile of any 
[35S]-methionine labeled D1 fraction bands mi- 
grating faster than the 69 kDa marker protein 
[Fig. 3(b), lane 2]. Characteristic mAb 5D4 
immunoreactivity with fibromodulin [30] was also 
not detected in D1 fractions in this zone of the gel. 
We have, however, previously reported an mAb 2D3 
(anti-keratan sulfate mAb with reactivity similar to 
mAb 5D4) reactive product in nonenzyme digested 
D1 fractions of rabbit chondrocytes [16] so that if a 
keratan sulfate proteoglycan was present in these 
D1 fractions, our method would have detected it. 
Recent studies have refocused attention on 
phenotypic differences between human aged non- 
arthritic (often termed as 'normal cartilage') and 
osteoarthritic cartilage [2]. Specific elimination of 
osteophytic artilage in these analyses, however, 
was an important requirement since the osteophytic 
cartilage 'cap' represented tissue arising during the 
course of the osteoarthrit ic process and possessed 
several characteristics of hyaline cartilage [31, 32]. 
The cartilage obtained for the present analyses was 
typical of the samples we have used previously [33]. 
Although there was significant destruction of the 
articular surface of the femoral head at the time of 
joint replacement surgery, there were also areas 
('resident cartilage') retained on the femoral surface 
which were mildly discoloured or, at best, minimally 
fibrillated. This cartilage was generally obtained 
from the posterior or inferior aspect of the femoral 
head and was likely spared complete destruction 
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probably because it resided in a reduced-weight 
bearing site. Previous histochemical analysis, 
however, showed that this cartilage was character- 
ized by distinct signs of extracellular matrix 
degradation [33]. Some studies have attempted to 
compare 'histologically mild' osteoarthrit ic knee 
cartilage with 'normal' cartilage of the same joint 
[34]. These analyses revealed little difference 
between the proteoglycan synthesis capacity of the 
different topographical sites. We had previously 
shown that discoloured and fibrillated osteo- 
arthrit ic femoral head cartilage synthesized a
similar and overlapping profile of newly synthesized 
proteoglycans [35,36]. Differences in cartilage 
thickness between onarthrit ic and osteoarthritic 
cartilages may also confound the analysis of newly 
synthesized proteoglycans in explant culture [37], 
but intrinsic differences in proteoglycan synthesiz- 
ing capacity of osteoarthrit ic and normal cartilage 
in vitro [38] would also contribute to the results 
obtained in the present study. Maintenance of 
human chondrocytes in high-density monolayer 
culture or in agarose [39] apparently regulated and 
maintained a stable chondrocyte phenotype. Thus, 
human chondrocytes from osteoarthritic cartilage 
maintained at high density, as did human os- 
teoarthrit ic cartilage, actively transcribed the 
COL2A1 [40], COL9A1 and COLllA1 genes 
(unpublished observations). 
Although the present study did not attempt o 
quantify the $1 and $2 core protein synthesis by 
human chondrocytes (Fig. 6), visual inspection of 
the autoradiographs suggested increased small 
proteoglycan synthesis by chondrocytes from 
osteoarthritic cartilage. Thus, the increased con- 
tent of these small proteoglycans in osteoarthritic 
cartilage [9] and the association of dermatan-sulfate 
proteoglycans with anti-adhesive properties 
of extracellular matrix [41, 42] may also contribute 
to abortive attempts at repair of osteoarthritic 
cartilage lesions. 
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